The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
Applications of nanoparticle systems in drug delivery technology
Open accessAbstract
The development of nanoparticle-based drug formulations has yielded the opportunities to address and treat challenging diseases. Nanoparticles vary in size but are generally ranging from 100 to 500 nm. Through the manipulation of size, surface characteristics and material used, the nanoparticles can be developed into smart systems, encasing therapeutic and imaging agents as well as bearing stealth property. Further, these systems can deliver drug to specific tissues and provide controlled release therapy. This targeted and sustained drug delivery decreases the drug related toxicity and increase patient's compliance with less frequent dosing. Nanotechnology has proven beneficial in the treatment of cancer, AIDS and many other disease, also providing advancement in diagnostic testing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Quantum Dots for Live Cells, in Vivo Imaging, and Diagnostics
Michalet, X., Pinaud, F. F., Bentolila, L. A., Tsay, J. M., Doose, S., Li, J. J., Sundaresan, G., Wu, A. M., Gambhir, S. S., & Weiss, S. (2005) · Science · doi:10.1126/science.1104274 · Cited by 7,790
Stimuli-responsive nanocarriers for drug delivery
Mura, S., Nicolas, J., & Couvreur, P. (2013) · Nature Materials · doi:10.1038/nmat3776 · Cited by 6,289
Nanomaterials and nanoparticles: Sources and toxicity
Buzea, C., Pacheco, I. I., & Robbie, K. (2007) · Biointerphases · doi:10.1116/1.2815690 · Cited by 3,789
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
Nanoparticle-based targeted drug delivery
Singh, R., & Lillard, J. W. (2009) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2008.12.004 · Cited by 2,734
Polymer-based nanocapsules for drug delivery
Mora-Huertas, C. E., Fessi, H., & Elaissari, A. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.10.018 · Cited by 1,742
Drug delivery systems: An updated review
Tiwari, G., Tiwari, R., Bannerjee, S., Bhati, L., Pandey, S., Pandey, P., & Sriwastawa, B. (2012) · International Journal of Pharmaceutical Investigation · doi:10.4103/2230-973x.96920 · Cited by 1,671
An overview of nanoparticles commonly used in fluorescent bioimaging
Wolfbeis, O. S. (2015) · Chemical Society Reviews · doi:10.1039/c4cs00392f · Cited by 1,631
New developments in liposomal drug delivery
Pattni, B. S., Chupin, V. V., & Torchilin, V. P. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00046 · Cited by 1,600
Imaging and drug delivery using theranostic nanoparticles
Janib, S. M., Moses, A. S., & MacKay, J. A. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.08.004 · Cited by 1,248
Bioavailability of resveratrol
Walle, T. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05842.x · Cited by 1,051
Shaikh, J., Ankola, D. D., Beniwal, V., Singh, D., & Kumar, M. N. V. R. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.02.019 · Cited by 956
Polymeric Micelles in Anticancer Therapy: Targeting, Imaging and Triggered Release
Oerlemans, C., Bult, W., Bos, M., Storm, G., Nijsen, J. F. W., & Hennink, W. E. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0233-4 · Cited by 947
Bioavailability of nanoparticles in nutrient and nutraceutical delivery
Acosta, E. (2009) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2008.01.002 · Cited by 874
The Mechanism of Uptake of Biodegradable Microparticles in Caco-2 Cells Is Size Dependent
Desai, M. P., Labhasetwar, V., Walter, E., Levy, R. J., & Amidon, G. L. (1997) · Pharmaceutical Research · doi:10.1023/a:1012126301290 · Cited by 858
Calvo, P., Remuñan-López, C., Vila-Jato, J. L., & Alonso, M. J. (1997) · Pharmaceutical Research · doi:10.1023/a:1012128907225 · Cited by 817
Mathematical modeling of bioerodible, polymeric drug delivery systems
Siepmann, J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00116-8 · Cited by 772
Chemical Basis of Interactions Between Engineered Nanoparticles and Biological Systems
Mu, Q., Jiang, G., Chen, L., Zhou, H., Fourches, D., Tropsha, A., & Yan, B. (2014) · Chemical Reviews · doi:10.1021/cr400295a · Cited by 679
Strategies for controlled delivery of growth factors and cells for bone regeneration
Vo, T. N., Kasper, F. K., & Mikos, A. G. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.01.016 · Cited by 666
Quintana, A., Raczka, E., Piehler, L., Lee, I., Myc, A., Majoros, I., Patri, A. K., Thomas, T., Mulé, J., & Baker, J. R. (2002) · Pharmaceutical Research · doi:10.1023/a:1020398624602 · Cited by 663
Controlled drug release from pharmaceutical nanocarriers
Lee, J. H., & Yeo, Y. (2015) · Chemical Engineering Science · doi:10.1016/j.ces.2014.08.046 · Cited by 628
Targeted Cancer Therapy: The Next Generation of Cancer Treatment
Baudino, T. (2015) · Current Drug Discovery Technologies · doi:10.2174/1570163812666150602144310 · Cited by 611
Kapetanovic, I. M., Muzzio, M., Huang, Z., Thompson, T. N., & McCormick, D. L. (2011) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-010-1525-4 · Cited by 609
The endocytosis and intracellular fate of nanomedicines: Implication for rational design
Kou, L., Sun, J., Zhai, Y., & He, Z. (2013) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2013.07.001 · Cited by 569
Stealth nanoparticles: High density but sheddable PEG is a key for tumor targeting
Li, S.-D., & Huang, L. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.03.016 · Cited by 562
Shape and Aggregation Control of Nanoparticles: Not Shaken, Not Stirred
Li, D., & Kaner, R. B. (2006) · Journal of the American Chemical Society · doi:10.1021/ja056609n · Cited by 548
Mohanty, C., & Sahoo, S. K. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.04.062 · Cited by 530
Simulation and prediction of in vivo drug metabolism in human populations from in vitro data
Rostami-Hodjegan, A., & Tucker, G. T. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2173 · Cited by 530
Microparticles and nanoparticles for drug delivery
Kohane, D. S. (2007) · Biotechnology and Bioengineering · doi:10.1002/bit.21301 · Cited by 517
Cheng, Y., Zhao, L., Li, Y., & Xu, T. (2011) · Chemical Society Reviews · doi:10.1039/c0cs00097c · Cited by 515
Innovative Preparation of Curcumin for Improved Oral Bioavailability
Sasaki, H., Sunagawa, Y., Takahashi, K., Imaizumi, A., Fukuda, H., Hashimoto, T., Wada, H., Katanasaka, Y., Kakeya, H., Fujita, M., et al. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.660 · Cited by 450
Resveratrol: Isomeric Molar Absorptivities and Stability
Trela, B. C., & Waterhouse, A. L. (1996) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf9504576 · Cited by 440
Targeted Liposomal Drug Delivery to Monocytes and Macrophages
Kelly, C., Jefferies, C., & Cryan, S.-A. (2011) · Journal of Drug Delivery · doi:10.1155/2011/727241 · Cited by 425
Nanodrugs: pharmacokinetics and safety
Onoue, S., Yamada, S., & Chan, K. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s38378 · Cited by 382
Quantum dots for fluorescent biosensing and bio-imaging applications
Li, J., & Zhu, J.-J. (2013) · The Analyst · doi:10.1039/c3an36705c · Cited by 369
The Smart Targeting of Nanoparticles
Friedman, A., Claypool, S., & Liu, R. (2013) · Current Pharmaceutical Design · doi:10.2174/13816128113199990375 · Cited by 364
Nanovehicular Intracellular Delivery Systems
Prokop, A., & Davidson, J. M. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21270 · Cited by 363
Targeted drug delivery via folate receptors
Zhao, X., Li, H., & Lee, R. J. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.3.309 · Cited by 358
McClements, D. J. (2015) · Journal of Food Science · doi:10.1111/1750-3841.12919 · Cited by 328
Elucidating mechanisms of drug-induced toxicity
Liebler, D. C., & Guengerich, F. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1720 · Cited by 323
Son, G.-H., Lee, B.-J., & Cho, C.-W. (2017) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-017-0320-1 · Cited by 320
Evolution of macromolecular complexity in drug delivery systems
Kakkar, A., Traverso, G., Farokhzad, O. C., Weissleder, R., & Langer, R. (2017) · Nature Reviews Chemistry · doi:10.1038/s41570-017-0063 · Cited by 320
Resveratrol nanoformulations: Challenges and opportunities
Summerlin, N., Soo, E., Thakur, S., Qu, Z., Jambhrunkar, S., & Popat, A. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.01.003 · Cited by 316
McClements, D. J., Li, F., & Xiao, H. (2015) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-032814-014043 · Cited by 315
The pinpoint promise of nanoparticle-based drug delivery and molecular diagnosis
Emerich, D. F., & Thanos, C. G. (2006) · Biomolecular Engineering · doi:10.1016/j.bioeng.2006.05.026 · Cited by 312
Active targeting of chemotherapy to disseminated tumors using nanoparticle-carrying T cells
Huang, B., Abraham, W. D., Zheng, Y., Bustamante López, S. C., Luo, S. S., & Irvine, D. J. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa5447 · Cited by 312
Bioavailability of encapsulated resveratrol into nanoemulsion-based delivery systems
Sessa, M., Balestrieri, M. L., Ferrari, G., Servillo, L., Castaldo, D., D’Onofrio, N., Donsì, F., & Tsao, R. (2014) · Food Chemistry · doi:10.1016/j.foodchem.2013.09.088 · Cited by 285
Tailoring nanoparticle designs to target cancer based on tumor pathophysiology
Sykes, E. A., Dai, Q., Sarsons, C. D., Chen, J., Rocheleau, J. V., Hwang, D. M., Zheng, G., Cramb, D. T., Rinker, K. D., & Chan, W. C. W. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1521265113 · Cited by 281
Emerging Nanotechnology Approaches for HIV/AIDS Treatment and Prevention
Mamo, T., Moseman, E. A., Kolishetti, N., Salvador-Morales, C., Shi, J., Kuritzkes, D. R., Langer, R., Andrian, U. V., & Farokhzad, O. C. (2010) · Nanomedicine · doi:10.2217/nnm.10.1 · Cited by 255
Neves, A. R., Queiroz, J. F., & Reis, S. (2016) · Journal of Nanobiotechnology · doi:10.1186/s12951-016-0177-x · Cited by 240
Targeted nanoparticle-based drug delivery and diagnosis
Emerich, D. F., & Thanos, C. G. (2007) · Journal of Drug Targeting · doi:10.1080/10611860701231810 · Cited by 228
Carbon Nanotubes: An Emerging Drug Carrier for Targeting Cancer Cells
Rastogi, V., Yadav, P., Bhattacharya, S. S., Mishra, A. K., Verma, N., Verma, A., & Pandit, J. K. (2014) · Journal of Drug Delivery · doi:10.1155/2014/670815 · Cited by 212
Kaminskas, L. M., Boyd, B. J., & Porter, C. J. (2011) · Nanomedicine · doi:10.2217/nnm.11.67 · Cited by 204
Aggarwal, B. B., Van Kuiken, M. E., Iyer, L. H., Harikumar, K. B., & Sung, B. (2009) · Experimental Biology and Medicine · doi:10.3181/0902-mr-78 · Cited by 203
Dendrimer-based nanoparticles for cancer therapy
Baker, J. R. (2009) · Hematology · doi:10.1182/asheducation-2009.1.708 · Cited by 191
Arterial Uptake of Biodegradable Nanoparticles: Effect of Surface Modifications
Labhasetwar, V., Song, C., Humphrey, W., Shebuski, R., & Levy, R. J. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js980021f · Cited by 190
Autophagy-mediated chemosensitization in cancer cells by fullerene C60 nanocrystal
Zhang, Q., Yang, W., Man, N., Zheng, F., Shen, Y., Sun, K., Li, Y., & Wen, L.-P. (2009) · Autophagy · doi:10.4161/auto.5.8.9842 · Cited by 185
Bantz, C., Koshkina, O., Lang, T., Galla, H.-J., Kirkpatrick, C. J., Stauber, R. H., & Maskos, M. (2014) · Beilstein Journal of Nanotechnology · doi:10.3762/bjnano.5.188 · Cited by 166
Sanna, V., Siddiqui, I. A., Sechi, M., & Mukhtar, H. (2013) · Molecular Pharmaceutics · doi:10.1021/mp400342f · Cited by 166
Carbon Nanotubes as an Effective Opportunity for Cancer Diagnosis and Treatment
Sanginario, A., Miccoli, B., & Demarchi, D. (2017) · Biosensors · doi:10.3390/bios7010009 · Cited by 165
Nanotechnology based approaches in cancer therapeutics
Biswas, A. K., Islam, M. R., Choudhury, Z. S., Mostafa, A., & Kadir, M. F. (2014) · Advances in Natural Sciences: Nanoscience and Nanotechnology · doi:10.1088/2043-6262/5/4/043001 · Cited by 160
Intracellular Delivery of Saquinavir in Biodegradable Polymeric Nanoparticles for HIV/AIDS
Shah, L. K., & Amiji, M. M. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9101-7 · Cited by 155
Resveratrol content of some wines obtained from dried Valpolicella grapes: Recioto and Amarone
Celotti, E., Ferrarini, R., Zironi, R., & Conte, L. S. (1996) · Journal of Chromatography A · doi:10.1016/0021-9673(95)00962-0 · Cited by 145
Cell Delivery of Therapeutic Nanoparticles
McMillan, J., Batrakova, E. V., & Gendelman, H. E. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-416020-0.00014-0 · Cited by 141
Venuti, V., Cannavà, C., Cristiano, M. C., Fresta, M., Majolino, D., Paolino, D., Stancanelli, R., Tommasini, S., & Ventura, C. A. (2013) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2013.11.025 · Cited by 133
Influence of the Surfactant Concentration on the Body Distribution of Nanoparticles
Araújo, L. C. D. P., Löbenberg, R., & Kreuter, J. (1999) · Journal of drug targeting · doi:10.3109/10611869908996844 · Cited by 133
Enhancing delivery and cytotoxicity of resveratrol through a dual nanoencapsulation approach
Soo, E., Thakur, S. S., Qu, Z. G., et al. (2015) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2015.10.022 · Cited by 129
Targeted Imaging and Therapy of Brain Cancer Using Theranostic Nanoparticles
Bhojani, M. S., Dort, M. V., Rehemtulla, A., & Ross, B. D. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100298r · Cited by 129
Lindner, G. D. R., Santos, D. B., Colle, D., Moreira, E. L. G., Prediger, R. D., Farina, M., Khalil, N. M., & Mainardes, R. M. (2015) · Nanomedicine · doi:10.2217/nnm.14.165 · Cited by 127
Fullerenes for Cancer Diagnosis and Therapy: Preparation, Biological and Clinical Perspectives
Chen, Z., Mao, R., & Liu, Y. (2012) · Current Drug Metabolism · doi:10.2174/138920012802850128 · Cited by 125
Shen, B., Ma, Y., Yu, S., & Ji, C. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b09772 · Cited by 125
Polymer‐surfactant nanoparticles for sustained release of water‐soluble drugs
Chavanpatil, M. D., Khdair, A., Patil, Y. B., Handa, H., Mao, G., & Panyam, J. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20961 · Cited by 124
Progress in antiretroviral drug delivery using nanotechnology
Rohan, L. C., & Mallipeddi (2010) · International Journal of Nanomedicine · doi:10.2147/ijn.s7681 · Cited by 122
Combination antiretroviral drugs in PLGA nanoparticle for HIV-1
Destache, C. J., Belgum, T., Christensen, K. J., Shibata, A., Sharma, A. D., & Dash, A. K. (2009) · BMC Infectious Diseases · doi:10.1186/1471-2334-9-198 · Cited by 115
Nowacek, A. S., McMillan, J., Miller, R., Anderson, A. K., Rabinow, B. E., & Gendelman, H. E. (2010) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-010-9198-7 · Cited by 107
Catania, A., Barrajón‐Catalán, E., Nicolosi, S., Cicirata, F., & Micol, V. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2667-y · Cited by 104
Varshosaz, J., & Farzan, M. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i42.12022 · Cited by 104
Targeting anti-HIV drugs to the CNS
Rao, K. S., Ghorpade, A., & Labhasetwar, V. D. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240903081705 · Cited by 100
Central nervous system complications of HIV infection.
Luetkemeyer, A. F., Havlir, D. V., & Currier, J. S. (2011) · Europe PMC (PubMed Central) · Cited by 89
Murugesan, S., Mousa, S. A., O’Connor, L. J., Lincoln, D. W., & Linhardt, R. J. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.02.022 · Cited by 79
Applications of Dendrimers for Brain Delivery and Cancer Therapy
Somani, S., & Dufès, C. (2014) · Nanomedicine · doi:10.2217/nnm.14.130 · Cited by 72
Engineering biodegradable nanoparticles for drug and gene delivery.
Zhang, J., & Saltzman, W. M. (2013) · PubMed · Cited by 61
Pramanik, A., SiddikUzzaman, B. S. P., Palanimuthu, D., Somasundaram, K., & Samuelson, A. G. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00537 · Cited by 61
Kolluru, L. P., Rizvi, S. A. A., D’Souza, M., & D’Souza, M. J. (2012) · Journal of drug targeting · doi:10.3109/1061186x.2012.729214 · Cited by 48
Self-citationRevolutionary Impact of Nanodrug Delivery on Neuroscience
Khanbabaie, R., & Jahanshahi, M. (2012) · Current Neuropharmacology · doi:10.2174/157015912804143513 · Cited by 47
Revolutionary Impact of Nanodrug Delivery on Neuroscience
Khanbabaie, R., & Jahanshahi, M. (2012) · Current Neuropharmacology · doi:10.2174/157015912804499456 · Cited by 47
Nanoparticle Delivery: Targeting and Nonspecific Binding
Liu, R., Kay, B. K., Jiang, S., & Chen, S. (2009) · MRS Bulletin · doi:10.1557/mrs2009.119 · Cited by 46
Nanomicellar Carriers for Targeted Delivery of Anticancer Agents
Zhang, X., Huang, Y., & Li, S. (2013) · Therapeutic Delivery · doi:10.4155/tde.13.135 · Cited by 45
Moss, J. A. (2013) · PubMed · Cited by 45
Potential of polymeric nanoparticles in AIDS treatment and prevention
Khalil, N. M., Carraro, E., Cótica, L. F., & Mainardes, R. M. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.543673 · Cited by 41
Nanotechnology – The New Frontier of Medicine
Datta, R., & Jaitawat, S. (2006) · Medical Journal Armed Forces India · doi:10.1016/s0377-1237(06)80016-x · Cited by 18
Novel approach for preparing nontoxic stealth microspheres for drug delivery
Angra, P., Rizvi, S. A. A., Oettinger, C. W., & D’Souza, M. J. (2011) · European Journal of Chemistry · doi:10.5155/eurjchem.2.2.125-129.394 · Cited by 11
Self-citation
Cited by
The Role of Ligands in the Chemical Synthesis and Applications of Inorganic Nanoparticles
Heuer-Jungemann, A., Feliu, N., Bakaimi, I., Hamaly, M., Alkilany, A., Chakraborty, I., Masood, A., Casula, M. F., Kostopoulou, A., Oh, E., et al. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00733 · Cited by 1,279
Therapeutic Nanoparticles and Their Targeted Delivery Applications
Yetisgin, A. A., Cetinel, S., Zuvin, M., Kosar, A., & Kutlu, O. (2020) · Molecules · doi:10.3390/molecules25092193 · Cited by 1,080
Advances in drug delivery systems, challenges and future directions
Ezike, T. C., Okpala, U. S., Onoja, U. L., Nwike, C. P., Ezeako, E. C., Okpara, O. J., Okoroafor, C. C., Eze, S. C., Kalu, O. L., Odoh, E. C., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e17488 · Cited by 1,040
Therapeutic Potential of Quercetin: New Insights and Perspectives for Human Health
Salehi, B., Machin, L., Monzote, L., Sharifi-Rad, J., Ezzat, S. M., Salem, M. A., Merghany, R. M., El Mahdy, N. M., Kılıç, C. S., Sytar, O., et al. (2020) · ACS Omega · doi:10.1021/acsomega.0c01818 · Cited by 707
Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles
Singh, A. P., Biswas, A., Shukla, A., & Maiti, P. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0068-3 · Cited by 645
Metadata
- Authors
- Rizvi, S. A. A., & Saleh, A. M.
- Venue
- Saudi Pharmaceutical Journal
- Published
- 2018-01
- Volume
- 26
- Issue
- 1
- Pages
- 64-70
- ISSN
- 1319-0164 (ISSN-L)
- OpenAlex
- W2765178824
- Cited by
- 1,334
- References
- 93
- FWCI
- 32.30
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.